Max Robotics — Global Service Robot Directory + US Certification

About

Shaoli Liu is a biomedical engineer and researcher whose work spans two compelling frontiers: DNA nanotechnology for cancer therapy and robotic-assisted surgical systems for tumor treatment. Liu's most celebrated contribution is the landmark 2018 paper "A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo," which has amassed an extraordinary 1,480 citations, reflecting its transformative impact on the field of programmable nanomedicine. This work demonstrated that DNA nanorobots could be engineered to deliver therapeutic payloads selectively in response to tumor-specific molecular signals, opening new avenues for precision cancer treatment. Beyond nanotechnology, Liu has made meaningful contributions to robotic-assisted liver tumor ablation, developing intelligent surgical planning frameworks — including automatic multiple-needle planning and collision-free workspace optimization — that improve both the safety and efficacy of microwave coagulation therapy for large liver tumors. These systems address the critical challenge of minimizing damage to healthy tissue while maximizing treatment accuracy. Though earlier publications in this domain carry modest citation counts, they collectively represent a coherent research vision focused on translating computational and robotic innovation into clinically meaningful cancer interventions. Liu's body of work exemplifies the integration of engineering precision with life-saving medical application.